Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The DNA Diagnostics Market Expected To Grow In Terms Of Size?

The scale of the DNA diagnostics market has seen a quick expansion in the past few years. It is anticipated to rise from $23.1 billion in 2024 to $25.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.9%. Factors contributing to growth during the historical period include the surging demand for customized medicine, the escalating acceptance of genetic testing and molecular diagnostics in clinical operations, increasing biomedical research, a growing number of cancer patients, and an enhanced utilization of diagnostic tests.

In the coming years, the DNA diagnostics market is anticipated to observe robust growth. It’s projected to reach a value of $37.35 billion in 2029, expanding at a compound annual growth rate (CAGR) of 9.9%. Factors driving growth in the forecast period include the rising incidence of cancer, heightened demand for standardized diagnostic evaluations, increasing occurrence of genetic disorders, augmented focus on unveiling biomarkers, rare diseases and orphan drugs, and the growth of telemedicine and remote testing. Significant trends in this period incorporate microbiome analysis integration, blockchain technology integration, the amalgamation of various omics data, non-invasive testing approaches, multi-omics integration, enabling portable and point-of-care DNA diagnostic tools, and advancements in next-generation sequencing (NGS).

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15356&type=smp

What Are The Primary Factors Supporting The DNA Diagnostics Market Expansion?

The escalation of genetic defects is anticipated to boost the expansion of the DNA diagnostics market in the future. Genetic disorders are health issues triggered by one or several irregularities located within the genome. The escalating instances of these disorders occur due to improved diagnostic technologies, broadened genetic examinations, environmental impacts, and inbreeding among populations, which all contribute to enhanced knowledge and recognition of genetic disorder-related conditions. DNA diagnostics, through the analysis of genetic materials, allows for precise detection of genetic disorders paving the way for early diagnosis, tailored treatments, and well-informed familial planning decisions. For example, in February 2023, congenital illnesses were reported by the World Health Organization (WHO) to be the cause of roughly 240,000 infant fatalities worldwide, within 28 days post-birth annually. Furthermore, congenital diseases lead to the death of an added 170,000 children aged between 1 month and 5 years. Consequently, the escalation in genetic disorders is fueling the expansion of the DNA diagnostics market.

Which Segmentation Categories Are Highlighted In The DNA Diagnostics Market Analysis?

The dna diagnosticsmarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents; Software And Services

2) By Technology: Polymerase Chain Reaction; Microarray; In-situ Hybridization; Sequencing Technology; Mass Spectrometry

3) By Application: Oncology; Infectious Diseases Treatment; Myogenic Disorder Treatment; Clinical Diagnostic Confirmation; Prenatal; Pre-Implantation; Other Applications

4) By End User: Point Of Care; Diagnostic Centers; Self-Testing Or Over-The-Counter (OTC)

Subsegments:

1) By Instruments: DNA Analyzers; PCR Machines (Polymerase Chain Reaction); Sequencers (Next-Generation Sequencing, Sanger Sequencing); Electrophoresis Systems; Gene Expression Analyzers; Microarray Systems; Flow Cytometers; Spectrophotometers

2) By Reagents: PCR Reagents; DNA Extraction Kits; Sequencing Reagents; Antibodies For DNADetection; Fluorescent Dyes And Probes; Chemicals For Nucleic Acid Purification; Buffer Solutions For DNA Analysis; Hybridization And Amplification Kits

3) By Software: DNA Data Analysis Software; Bioinformatics Platforms; Genomics Software For Sequencing Data; Laboratory Information Management Systems (LIMS); Data Visualization Tools; Genetic Variant Analysis Software; Genome Mapping Software

4) By Services: Genetic Testing Services; DNA Sequencing Services; Bioinformatics Consulting And Analysis; Clinical Diagnostic Services; Genetic Counseling Services; Custom DNA Diagnostics Services; Research And Development Services

Which Trends Are Likely To Redefine Growth Paths In The DNA Diagnostics Market?

Prominent players in the DNA diagnostics sector are channeling their efforts into creating groundbreaking product offerings such as liquid biopsy tests to enable early detection of varying types of cancer. The liquid biopsy is a less invasive medical diagnostic procedure that identifies and investigates biomarkers, which could be circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes that have been released into the blood from tumors or other cells. For instance, Laboratory Corporation, an American healthcare diagnostics company, launched a new liquid biopsy test named LabCorp Plasma Focus in May 2023. This innovative test makes use of genetic sequencing to assess circulating cell-free DNA (cfDNA) shed by tumor cells, thereby enabling oncologists to provide tailored and improved patient care via targeted treatment plans.

Which Organizations Are At The Forefront Of The DNA Diagnostics Market?

Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Which Geographic Regions Are Creating Strong Demand In The DNA Diagnostics Market?

North America was the largest region in the DNA diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15356&type=smp

Browse Through More Reports Similar to the Global DNA Diagnostics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Recombinant Dna Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Prenatal Dna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model